Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Lin, L

Class:Id	Person:2011640
_displayName	Lin, L
_timestamp	2011-11-22 14:24:09
created	[InstanceEdit:2011639] Rothfels, K, 2011-11-22
firstname	Lin
initial	L
surname	Lin
(author)	[LiteratureReference:2012018] SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas [LiteratureReference:3656366] Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity [LiteratureReference:5580276] Severe combined adrenal and gonadal deficiency caused by novel mutations in the cholesterol side chain cleavage enzyme, P450scc [LiteratureReference:9649118] Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials [LiteratureReference:9670202] Trp2313-His2315 of factor VIII C2 domain is involved in membrane binding: structure of a complex between the C2 domain and an inhibitor of membrane binding [LiteratureReference:9762924] Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogramming [LiteratureReference:9771991] BAP18 coactivates androgen receptor action and promotes prostate cancer progression [LiteratureReference:9856996] Biochemical Characterization and Structure-Based Mutational Analysis Provide Insight into the Binding and Mechanism of Action of Novel Aspartate Aminotransferase Inhibitors
[Change default viewing format]

No pathways have been reviewed or authored by Lin, L (2011640)